<--- Back to Details
First PageDocument Content
Blood tests / Medicine / Heparins / Low molecular weight heparin / Partial thromboplastin time / Prothrombin time / Thromboplastin / Anticoagulant / Coagulation / Hematology / Blood / Coagulation system
Date: 2006-11-06 14:33:05
Blood tests
Medicine
Heparins
Low molecular weight heparin
Partial thromboplastin time
Prothrombin time
Thromboplastin
Anticoagulant
Coagulation
Hematology
Blood
Coagulation system

Laboratory Testing Prac Post2.cdr

Add to Reading List

Source URL: wwwn.cdc.gov

Download Document from Source Website

File Size: 420,36 KB

Share Document on Facebook

Similar Documents

Blood tests / Coagulation system / Thrombin time / Thromboplastin / Coagulation testing / Fibrinogen / Prothrombin time / Partial thromboplastin time / Coagulation / Thrombin / Venipuncture / Anticoagulant

Veterinärmedizinisches Labor Universität Zürich Winterthurerstrasse 260 CH-8057 Zürich Telefon +Telefax +

DocID: 1powD - View Document

Anatomy / Blood tests / Coagulation / Prothrombin time / Thromboplastin / Fibrinogen / Thrombin / Antithrombin / Partial thromboplastin time / Blood / Coagulation system / Hematology

Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen

DocID: 1aOgJ - View Document

Blood / Low molecular weight heparin / Factor X / Coagulation / Anticoagulant / Partial thromboplastin time / Heparins / Hematology / Coagulation system

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of M118, a Novel Rationally Engineered Low Molecular Weight Heparin Given as a Subcutaneous Injection in a Rising Dose Cohort Regimen in Healthy Subjects S. Bou

DocID: 19tt1 - View Document

Heparins / Anatomy / Low molecular weight heparin / Factor X / Coagulation / UFH / Antithrombin / Partial thromboplastin time / Anticoagulant / Blood / Coagulation system / Hematology

Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

DocID: 19s56 - View Document

Low molecular weight heparin / Factor X / Coagulation / Protamine sulfate / Partial thromboplastin time / Vitamin A / Biology / Heparins / Coagulation system / Medicine

Figure 2: Mean ACT with Increasing Dose of M118

DocID: 19obY - View Document